Overview: Toxoplasma IgM TestIntroduction: The Toxoplasma IgM Test detects toxoplasma IgM to diagnose recent infection, causing fever or fatigue. Aligned with 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected recent toxoplasmosis.
Other Names: Toxoplasma IgM Assay, Anti-Toxoplasma IgM Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Toxoplasma IgM testing began in the 1970s with infection research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects toxoplasma IgM to diagnose recent infection, guides treatment, and evaluates patients with fever or fatigue.
Test Parameters: 1. Toxoplasma IgM Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of fever, fatigue, or toxoplasmosis exposure.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, fatigue, or history of toxoplasmosis exposure. Include current medications, especially antiparasitics.
Consent: Written consent required, detailing the tests purpose, toxoplasmosis implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to detect toxoplasma IgM antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for recent infection diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. False positives may occur with autoimmune conditions.
Clinical Significance: Positive IgM confirms recent toxoplasma infection, guiding antiparasitic therapy. Negative results may require PCR or avidity testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Toxoplasma IgG, PCR, or avidity testing to confirm infection status.
Test Limitations: False positives possible; clinical correlation is needed. Sample quality affects sensitivity.
References: CDC Toxoplasmosis Guidelines, 2023; Clinical Infectious Diseases, Robert-Gangneux F, 2022.
